Category Archives: Schizophrenia

Progressive research is offering new hope across all ages

The most important investment in our country, from both a social and economic perspective, is in the well-being of its citizens through health and medical research. Tackling the growing impact of mental illness is imperative, and given our ageing population, the neurodegenerative conditions mean that over 350,000 Australians are living with dementia. This requires a sustained and comprehensive commitment from […]

Read more

Our progressive research offers new hope across all ages

The most important investment in our country, from both a social and economic perspective, is in the well-being of its citizens through health and medical research. Tackling the growing impact of mental illness is imperative, and given our ageing population, the neurodegenerative conditions mean that over 350,000 Australians are living with dementia. This requires a sustained and comprehensive commitment from […]

Read more

NEURA MAGAZINE #16 IS OUT!

The Autumn 2016 edition of the NeuRA Magazine is ready to read! This quarter, we discuss with Prof Rhoshel Lenroot how fathers can help future generations in Like Father Like Son. You can also read about Leanne O’Reilly’s participation in the CATS study with the schizophrenia laboratory. And catch up with Dr Claire Shepherd, Manager of the Sydney Brain Bank […]

Read more

Volunteer for schizophrenia clinical trial

Volunteer call out: Canakinumab adjunctive treatment to reduce symptoms and improve cognition in people with schizophrenia displaying elevated blood inflammatory markers What is the purpose of the study? You are invited to participate in a research study of a human immune cell-line antibody upon language, memory, and symptoms of schizophrenia. This human immune cell-line antibody, canakinumab, is a class of […]

Read more

Guiding future research

Our scientists have been asked to compile a special edition of Schizophrenia Research, looking specifically at the hormones implicated in the disorder. The September issue of peer-reviewed journal Schizophrenia Research, will this year be guest-edited by Prof Cyndi Shannon Weickert with assistance from myself and Katie Allen (right). We were invited to bring together a collection of articles that examine […]

Read more

Blood brain barrier and psychosis

Prof Cyndi Shannon Weickert and her team of researchers are asking a question about schizophrenia that has not been answered before – Is the blood brain barrier compromised in psychosis? Schizophrenia and bipolar disorder are diseases that affect an estimated 680,000 people in Australia and cost the economy $4.7 billion a year, yet their pathogenic mechanisms are little understood. One […]

Read more

NSW government invests in merger to boost schizophrenia research

NSW Minister for Medical Research, Pru Goward, today announced an investment of $2.5 million to fund a landmark merger between Australia’s leading schizophrenia research organisations – NeuRA – Neuroscience Research Australia and the Schizophrenia Research Institute (SRI). “The best outcomes for the treatment of schizophrenia will be achieved through the opportunity of these institutes to join forces and share their […]

Read more
1 2 3